A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.
A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results
by | Jul 9, 2026 | Uncategorized | 0 comments
Recent Comments